Abstract
Limited to inadequate stem-cell doses, cord blood transplantation (UCBT) is accompanied by increased graft failure and delayed haematopoietic recovery. The conditioning regimen is critically important for engraftment, and numerous trials have been undertaken comparing the outcomes of IV Bu and TBI, but there are no comparative data for UCBT. We conducted a retrospective multicentre study to analyse the outcomes of IV Bu and TBI in UCBT patients with haematologic malignancies. Between 1 May, 2008 and 31 Mar, 31 2018, a total of 331 patients from the China Umbilical Cord Blood Transplantation Corporation (IV Bu, n = 131; TBI, n = 200) were evaluated. The cumulative incidence of neutrophil engraftment was 91.6% in the IV Bu/Cy cohort and 98.0% in the Cy/TBI cohort (P < 0.001). The median times to neutrophil engraftment were 16 and 19 days (P < 0.001), respectively. Multivariate analysis showed no statistical difference for nonrelapse mortality (hazard ratio [HR], 1.11; 95% confidence interval [CI], 0.66 to 1.86; P = 0.695), relapse (HR, 0.90; 95% CI, 0.50 to 1.60; P = 0.713) and overall survival (HR, 0.94; 95% CI, 0.61 to 1.44; P = 0.763) between the two conditioning regimens. Our results show that both IV Bu and TBI are valid mye...Continue Reading
References
Mar 1, 1990·British Journal of Haematology·E GluckmanL Drouet
Jun 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·G MichelJ P Jouet
Feb 15, 1993·Annals of Internal Medicine·G B McDonaldR A Clift
Jun 22, 2000·The New England Journal of Medicine·V RochaE Gluckman
Oct 6, 2000·Bone Marrow Transplantation·H T TranK W Chan
Jun 8, 2001·Blood·D BlaiseJ P Vernant
Jun 18, 2003·Cancer Chemotherapy and Pharmacology·Brunhild SchiltmeyerGeorg Hempel
Nov 27, 2004·The New England Journal of Medicine·Mary J LaughlinMary M Horowitz
Nov 27, 2004·The New England Journal of Medicine·Vanderson RochaUNKNOWN Eurocord-Netcord Registry
Oct 18, 2006·Journal of Korean Medical Science·Joon Sup SongHo Joon Im
Dec 1, 2007·Blood·Anthony H GoldstoneJacob M Rowe
Dec 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Celso A RodriguesVanderson Rocha
Oct 3, 2009·British Journal of Haematology·Colleen DelaneyFrederick R Appelbaum
Dec 24, 2009·Blood·Juliet N BarkerCladd E Stevens
Jan 9, 2010·Leukemia & Lymphoma·Xu Shi-XiaTang Xiang-Feng
Jun 19, 2010·The Lancet Oncology·Mary EapenUNKNOWN National Cord Blood Program of the New York Blood Center
Mar 20, 2013·Transplantation·Vanderson RochaFrancesco Frassoni
Aug 28, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnon NaglerMohamad Mohty
Sep 26, 2013·Blood·Edward A CopelanWael Saber
Oct 2, 2013·Blood·Christopher BredesonMarcelo C Pasquini
Apr 20, 2014·Blood·Philippe ArmandWael Saber
Oct 30, 2014·The New England Journal of Medicine·John E WagnerUNKNOWN Blood and Marrow Transplant Clinical Trials Network
Dec 23, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Madan H JagasiaMary E D Flowers
Dec 22, 2015·The Lancet. Haematology·Arnon NaglerMohamad Mohty
Apr 22, 2016·Blood·Gérard MichelJean-Hugues Dalle
Sep 8, 2016·The New England Journal of Medicine·Filippo MilanoColleen Delaney
Oct 26, 2016·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kenjiro MitsuhashiUNKNOWN Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation
Aug 16, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Xiaoyu ZhuZimin Sun
Dec 5, 2017·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Partow KebriaeiUNKNOWN Acute Leukemia Committee of the CIBMTR